# Darling Ingredients Inc.: financial statements, quarterly

DAR · NYSE · CIK 916540 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jan 2

Pages: [Overview](/companies/dar.md) · [Financials](/companies/dar/financials.md) · [Filings](/companies/dar/filings.md) · [Insiders](/companies/dar/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dar/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,625](/filings/0000916540-24-000030.md) | [1,614 d](/filings/0000916540-26-000008.md) | [1,420](/filings/0000916540-25-000014.md) | [1,455](/filings/0000916540-25-000023.md) | [1,422](/filings/0000916540-25-000031.md) | [1,418 d](/filings/0000916540-26-000008.md) | [1,381](/filings/0000916540-26-000013.md) | [1,482](/filings/0000916540-26-000023.md) | [1,564](/filings/0000916540-25-000031.md) | [1,710 d](/filings/0000916540-26-000008.md) | [1,551](/filings/0000916540-26-000013.md) | [1,724](/filings/0000916540-26-000023.md) |
| Cost of revenue | $m | [1,239](/filings/0000916540-24-000030.md) | [1,178 d](/filings/0000916540-26-000008.md) | [1,117](/filings/0000916540-25-000014.md) | [1,128](/filings/0000916540-25-000023.md) | [1,108](/filings/0000916540-25-000031.md) | [1,084 d](/filings/0000916540-26-000008.md) | [1,069](/filings/0000916540-26-000013.md) | [1,136](/filings/0000916540-26-000023.md) | [1,177](/filings/0000916540-25-000031.md) | [1,281 d](/filings/0000916540-26-000008.md) | [1,146](/filings/0000916540-26-000013.md) | [1,221](/filings/0000916540-26-000023.md) |
| Gross profit | $m | [386 d](/filings/0000916540-24-000030.md) | [436 d](/filings/0000916540-26-000008.md) | [304](/filings/0000916540-25-000014.md) | [327](/filings/0000916540-25-000023.md) | [314](/filings/0000916540-25-000031.md) | [334 d](/filings/0000916540-26-000008.md) | [311](/filings/0000916540-26-000013.md) | [346](/filings/0000916540-26-000023.md) | [387](/filings/0000916540-25-000031.md) | [429 d](/filings/0000916540-26-000008.md) | [405](/filings/0000916540-26-000013.md) | [503](/filings/0000916540-26-000023.md) |
| Selling, general and administrative | $m | [138](/filings/0000916540-24-000030.md) | [133 d](/filings/0000916540-26-000008.md) | [139](/filings/0000916540-25-000014.md) | [130](/filings/0000916540-25-000023.md) | [116](/filings/0000916540-25-000031.md) | [108 d](/filings/0000916540-26-000008.md) | [122](/filings/0000916540-26-000013.md) | [138](/filings/0000916540-26-000023.md) | [140](/filings/0000916540-25-000031.md) | [152 d](/filings/0000916540-26-000008.md) | [149](/filings/0000916540-26-000013.md) | [151](/filings/0000916540-26-000023.md) |
| Operating income | $m | [178](/filings/0000916540-24-000030.md) | [159 d](/filings/0000916540-26-000008.md) | [137](/filings/0000916540-25-000014.md) | [149](/filings/0000916540-25-000023.md) | [60.1](/filings/0000916540-25-000031.md) | [122 d](/filings/0000916540-26-000008.md) | [28.4](/filings/0000916540-26-000013.md) | [75.9](/filings/0000916540-26-000023.md) | [71.7](/filings/0000916540-25-000031.md) | [97.4 d](/filings/0000916540-26-000008.md) | [227](/filings/0000916540-26-000013.md) | [555](/filings/0000916540-26-000023.md) |
| Interest expense | $m | not reported | not reported | [62.9](/filings/0000916540-25-000014.md) | [69.2](/filings/0000916540-25-000023.md) | [66.8](/filings/0000916540-25-000031.md) | [54.9 d](/filings/0000916540-26-000008.md) | [58.0](/filings/0000916540-26-000013.md) | [51.9](/filings/0000916540-26-000023.md) | [56.9](/filings/0000916540-25-000031.md) | [55.5 d](/filings/0000916540-26-000008.md) | [54.1](/filings/0000916540-26-000013.md) | [55.5](/filings/0000916540-26-000023.md) |
| Income tax | $m | [(15.4)](/filings/0000916540-24-000030.md) | [7.2 d](/filings/0000916540-26-000008.md) | [3.9](/filings/0000916540-25-000014.md) | [0.8](/filings/0000916540-25-000023.md) | [(17.5)](/filings/0000916540-25-000031.md) | [(25.5) d](/filings/0000916540-26-000008.md) | [(1.2)](/filings/0000916540-26-000013.md) | [4.1](/filings/0000916540-26-000023.md) | [(1.2)](/filings/0000916540-25-000031.md) | [(11.0) d](/filings/0000916540-26-000008.md) | [38.6](/filings/0000916540-26-000013.md) | [111](/filings/0000916540-26-000023.md) |
| Net income | $m | [125](/filings/0000916540-24-000030.md) | [84.5 d](/filings/0000916540-26-000008.md) | [81.2](/filings/0000916540-25-000014.md) | [78.9](/filings/0000916540-25-000023.md) | [16.9](/filings/0000916540-25-000031.md) | [102 d](/filings/0000916540-26-000008.md) | [(26.2)](/filings/0000916540-26-000013.md) | [12.7](/filings/0000916540-26-000023.md) | [19.4](/filings/0000916540-25-000031.md) | [56.9 d](/filings/0000916540-26-000008.md) | [134](/filings/0000916540-26-000013.md) | [387](/filings/0000916540-26-000023.md) |
| Diluted EPS | $ per share | [0.77](/filings/0000916540-24-000030.md) | not reported | [0.50](/filings/0000916540-25-000014.md) | [0.49](/filings/0000916540-25-000023.md) | [0.11](/filings/0000916540-25-000031.md) | not reported | [(0.16)](/filings/0000916540-26-000013.md) | [0.08](/filings/0000916540-26-000023.md) | [0.12](/filings/0000916540-25-000031.md) | not reported | [0.83](/filings/0000916540-26-000013.md) | [2.41](/filings/0000916540-26-000023.md) |
| Basic EPS | $ per share | [0.78](/filings/0000916540-24-000030.md) | not reported | [0.51](/filings/0000916540-25-000014.md) | [0.49](/filings/0000916540-25-000023.md) | [0.11](/filings/0000916540-25-000031.md) | not reported | [(0.16)](/filings/0000916540-26-000013.md) | [0.08](/filings/0000916540-26-000023.md) | [0.12](/filings/0000916540-25-000031.md) | not reported | [0.85](/filings/0000916540-26-000013.md) | [2.44](/filings/0000916540-26-000023.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0000916540-23-000036.md) | [0.1](/filings/0000916540-25-000008.md) | [0.1](/filings/0000916540-24-000014.md) | [0.1](/filings/0000916540-24-000024.md) | [0.1](/filings/0000916540-24-000030.md) | [0.1](/filings/0000916540-26-000008.md) | [0.1](/filings/0000916540-25-000014.md) | [0.1](/filings/0000916540-25-000023.md) | [0.1](/filings/0000916540-25-000031.md) | [0.1](/filings/0000916540-26-000023.md) | [0.1](/filings/0000916540-26-000013.md) | [0.2](/filings/0000916540-26-000023.md) |
| Current assets | $bn | [1.8](/filings/0000916540-23-000036.md) | [1.9](/filings/0000916540-25-000008.md) | [1.6](/filings/0000916540-24-000014.md) | [1.5](/filings/0000916540-24-000024.md) | [1.5](/filings/0000916540-24-000030.md) | [1.4](/filings/0000916540-26-000008.md) | [1.5](/filings/0000916540-25-000014.md) | [1.5](/filings/0000916540-25-000023.md) | [1.5](/filings/0000916540-25-000031.md) | [1.6](/filings/0000916540-26-000023.md) | [1.6](/filings/0000916540-26-000013.md) | [1.8](/filings/0000916540-26-000023.md) |
| Total assets | $bn | [10.8](/filings/0000916540-23-000036.md) | [11.1](/filings/0000916540-25-000008.md) | [10.9](/filings/0000916540-24-000014.md) | [10.6](/filings/0000916540-24-000024.md) | [10.6](/filings/0000916540-24-000030.md) | [10.1](/filings/0000916540-26-000008.md) | [10.0](/filings/0000916540-25-000014.md) | [10.3](/filings/0000916540-25-000023.md) | [10.5](/filings/0000916540-25-000031.md) | [10.3](/filings/0000916540-26-000023.md) | [10.6](/filings/0000916540-26-000013.md) | [11.0](/filings/0000916540-26-000023.md) |
| Current liabilities | $bn | [1.0](/filings/0000916540-23-000036.md) | [1.0](/filings/0000916540-25-000008.md) | [1.0](/filings/0000916540-24-000014.md) | [1.0](/filings/0000916540-24-000024.md) | [1.1](/filings/0000916540-24-000030.md) | [1.0](/filings/0000916540-26-000008.md) | [1.0](/filings/0000916540-25-000014.md) | [1.0](/filings/0000916540-25-000023.md) | [1.0](/filings/0000916540-25-000031.md) | [1.0](/filings/0000916540-26-000023.md) | [1.0](/filings/0000916540-26-000013.md) | [1.1](/filings/0000916540-26-000023.md) |
| Total liabilities | $bn | [6.3](/filings/0000916540-23-000036.md) | [6.4](/filings/0000916540-25-000008.md) | [6.3](/filings/0000916540-24-000014.md) | [6.1](/filings/0000916540-24-000024.md) | [5.9](/filings/0000916540-24-000030.md) | [5.6](/filings/0000916540-26-000008.md) | [5.5](/filings/0000916540-25-000014.md) | [5.6](/filings/0000916540-25-000023.md) | [5.7](/filings/0000916540-25-000031.md) | [5.5](/filings/0000916540-26-000023.md) | [5.7](/filings/0000916540-26-000013.md) | [5.7](/filings/0000916540-26-000023.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [4.4](/filings/0000916540-23-000036.md) | [4.6](/filings/0000916540-25-000008.md) | [4.6](/filings/0000916540-24-000014.md) | [4.5](/filings/0000916540-24-000024.md) | [4.6](/filings/0000916540-24-000030.md) | [4.4](/filings/0000916540-26-000008.md) | [4.4](/filings/0000916540-25-000014.md) | [4.6](/filings/0000916540-25-000023.md) | [4.7](/filings/0000916540-25-000031.md) | [4.7](/filings/0000916540-26-000023.md) | [4.9](/filings/0000916540-26-000013.md) | [5.2](/filings/0000916540-26-000023.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [277 d](/filings/0000916540-24-000030.md) | [217 d](/filings/0000916540-26-000008.md) | [264](/filings/0000916540-25-000014.md) | [147 d](/filings/0000916540-25-000023.md) | [274 d](/filings/0000916540-25-000031.md) | [154 d](/filings/0000916540-26-000008.md) | [249](/filings/0000916540-26-000013.md) | [146 d](/filings/0000916540-26-000023.md) | [224 d](/filings/0000916540-25-000031.md) | [441 d](/filings/0000916540-26-000008.md) | [153](/filings/0000916540-26-000013.md) | [533 d](/filings/0000916540-26-000023.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0000916540-24-000030.md) | [0.0 d](/filings/0000916540-26-000008.md) | [0.0](/filings/0000916540-25-000014.md) | [29.2 d](/filings/0000916540-25-000023.md) | [0.0 d](/filings/0000916540-25-000031.md) | [5.1 d](/filings/0000916540-26-000008.md) | [34.7](/filings/0000916540-26-000013.md) | [0.0 d](/filings/0000916540-26-000023.md) | [0.0 d](/filings/0000916540-25-000031.md) | [0.0 d](/filings/0000916540-26-000008.md) | [0.0](/filings/0000916540-26-000013.md) | [73.4 d](/filings/0000916540-26-000023.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [164](/filings/0000916540-23-000036.md) | [163](/filings/0000916540-24-000014.md) | [162](/filings/0000916540-24-000024.md) | [162](/filings/0000916540-24-000030.md) | [162](/filings/0000916540-25-000014.md) | [162](/filings/0000916540-25-000023.md) | [161](/filings/0000916540-25-000031.md) | [159](/filings/0000916540-26-000013.md) | [160](/filings/0000916540-26-000023.md) | [160](/filings/0000916540-25-000031.md) | [161](/filings/0000916540-26-000013.md) | [161](/filings/0000916540-26-000023.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 157,802,916 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0000916540-26-000023.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.